Compound Evidence File
#EC-2026-0017
PEG MGF
Filed under Peptides. The bureau holds 187 laboratory returns for this compound from 64 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
64 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 5 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 4 | 10.0 | 9.9 | 10.0 | 9 Apr 2026 | 13 Jun 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 4 | 10.0 | 9.9 | 10.0 | 12 Dec 2025 | 8 Jul 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 3 | 10.0 | 10.0 | 10.0 | 12 Nov 2025 | 10 Jun 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 3 | 10.0 | 9.9 | 10.0 | 23 Apr 2026 | 27 May 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 3 | 10.0 | 9.9 | 10.0 | 18 Nov 2025 | 2 Jun 2026 |
| BachemCASE #VI-2026-0314 | A | 3 | 10.0 | 10.0 | 10.0 | 12 May 2026 | 22 Jun 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 3 | 10.0 | 9.9 | 10.0 | 11 May 2026 | 28 Jun 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 3 | 10.0 | 10.0 | 10.0 | 27 Mar 2026 | 28 Jun 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 3 | 10.0 | 10.0 | 10.0 | 1 Apr 2026 | 26 Jun 2026 |
| AsymchemCASE #VI-2026-0091 | A | 3 | 10.0 | 9.9 | 10.0 | 8 Jul 2026 | 14 Aug 2026 |
| NUPEPS PeptidesCASE #VI-2026-0896 | X | 1 | 10.0 | 10.0 | 10.0 | 7 May 2025 | 7 May 2025 |
| HomopeptideCASE #VI-2026-0760 | A | 5 | 9.9 | 9.9 | 10.0 | 21 May 2026 | 21 May 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 4 | 9.9 | 9.9 | 10.0 | 22 Nov 2025 | 7 Jul 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 4 | 9.9 | 9.9 | 9.9 | 18 Feb 2026 | 9 Jul 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 4 | 9.9 | 9.9 | 10.0 | 16 Mar 2026 | 17 Jul 2026 |
| SinoPepCASE #VI-2026-0387 | A | 4 | 9.9 | 9.9 | 10.0 | 3 Apr 2026 | 13 Aug 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 3 | 9.9 | 9.9 | 10.0 | 2 Apr 2026 | 14 Jul 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 3 | 9.9 | 9.9 | 10.0 | 9 Jan 2026 | 8 Jun 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 3 | 9.9 | 9.9 | 10.0 | 10 May 2026 | 7 Jun 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 2 | 9.9 | 9.9 | 10.0 | 17 Feb 2026 | 25 Feb 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 2 | 9.9 | 9.9 | 10.0 | 4 Apr 2026 | 28 Jun 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 2 | 9.9 | 9.9 | 10.0 | 2 Jun 2026 | 11 Jul 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 2 | 9.9 | 9.9 | 9.9 | 19 Mar 2026 | 24 Jul 2026 |
| Lux Synth AminosCASE #VI-2026-0700 | X | 1 | 9.6 | 9.6 | 9.6 | 3 Jul 2025 | 3 Jul 2025 |
| Henan Sahe PeptideCASE #VI-2026-0894 | X | 1 | 9.4 | 9.4 | 9.4 | 24 Apr 2025 | 24 Apr 2025 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 6 | 8.6 | 7.2 | 10.0 | 24 May 2026 | 24 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 2 | 8.6 | 8.4 | 8.8 | 24 May 2026 | 24 May 2026 |
| Shanghai Leader Peptide BiotechnologyCASE #VI-2026-0558 | X | 1 | 8.5 | 8.5 | 8.5 | 8 Jul 2025 | 8 Jul 2025 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 5 | 8.4 | 7.0 | 9.9 | 25 May 2026 | 25 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 6 | 8.3 | 6.9 | 9.1 | 24 May 2026 | 24 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 7 | 8.2 | 6.9 | 9.0 | 25 May 2026 | 25 May 2026 |
| Peptide-SCASE #VI-2026-0111 | X | 11 | 8.2 | 4.7 | 10.0 | 24 Apr 2025 | 24 May 2026 |
| YB PeptideCASE #VI-2026-0813 | X | 1 | 7.8 | 7.8 | 7.8 | 2 Apr 2025 | 2 Apr 2025 |
| BfflinkCASE #VI-2026-0212 | X | 1 | 7.7 | 7.7 | 7.7 | 13 Feb 2025 | 13 Feb 2025 |
| Shandong Shengyuan Peptide TechnologyCASE #VI-2026-0634 | X | 2 | 7.5 | 7.1 | 8.0 | 13 Jun 2025 | 17 May 2026 |
| Yabang PeptideCASE #VI-2026-0148 | X | 1 | 7.4 | 7.4 | 7.4 | 25 Apr 2025 | 25 Apr 2025 |
| Bio PepzCASE #VI-2026-0436 | X | 1 | 7.3 | 7.3 | 7.3 | 13 Feb 2025 | 13 Feb 2025 |
| NexaphCASE #VI-2026-0944 | X | 8 | 6.8 | 5.0 | 10.0 | 3 Jul 2025 | 21 May 2026 |
| Hebei Rimao TechnologyCASE #VI-2026-0529 | X | 3 | 6.6 | 4.8 | 8.2 | 2 Jul 2025 | 25 May 2026 |
| Zhang TYCASE #VI-2026-0070 | X | 1 | 6.6 | 6.6 | 6.6 | 14 Jan 2025 | 14 Jan 2025 |
| ZZQ PeptidesCASE #VI-2026-0550 | E | 2 | 6.5 | 6.4 | 6.5 | 21 May 2025 | 26 Jan 2026 |
| OupeptideCASE #VI-2026-0435 | X | 11 | 6.4 | 4.8 | 8.4 | 24 Apr 2025 | 23 May 2026 |
| Diju Peptides Wellness and CoCASE #VI-2026-0724 | X | 1 | 6.4 | 6.4 | 6.4 | 2 Jul 2025 | 2 Jul 2025 |
| UWA Elite PeptidesCASE #VI-2026-0130 | X | 1 | 6.1 | 6.1 | 6.1 | 16 Mar 2025 | 16 Mar 2025 |
| TSC Top Supplements ChinaCASE #VI-2026-0523 | X | 9 | 6.0 | 3.6 | 8.5 | 3 Jun 2025 | 21 May 2026 |
| Hangzhou Mandy BiotechnologyCASE #VI-2026-0695 | X | 1 | 6.0 | 6.0 | 6.0 | 24 Apr 2025 | 24 Apr 2025 |
| PurePEPSCASE #VI-2026-0552 | X | 1 | 5.9 | 5.9 | 5.9 | 17 Dec 2024 | 17 Dec 2024 |
| ZLZ PeptideCASE #VI-2026-0524 | X | 9 | 5.8 | 3.7 | 8.5 | 17 Dec 2024 | 26 Jan 2026 |
| Shandong Nuoweiou Medical Technology CoCASE #VI-2026-0076 | X | 1 | 5.6 | 5.6 | 5.6 | 2 Apr 2025 | 2 Apr 2025 |
| Prime PeptidesCASE #VI-2026-0696 | X | 1 | 5.5 | 5.5 | 5.5 | 7 May 2025 | 7 May 2025 |
| LN PeptidesCASE #VI-2026-0781 | X | 1 | 5.5 | 5.5 | 5.5 | 16 Mar 2025 | 16 Mar 2025 |
| LSPLCASE #VI-2026-0523 | X | 1 | 5.4 | 5.4 | 5.4 | 13 Feb 2025 | 13 Feb 2025 |
| Elite Research USACASE #VI-2026-0267 | X | 4 | 5.3 | 4.0 | 7.6 | 3 Jun 2025 | 24 May 2026 |
| M-PeptidesCASE #VI-2026-0442 | X | 1 | 5.2 | 5.2 | 5.2 | 16 Mar 2025 | 16 Mar 2025 |
| Regenerative ResearchCASE #VI-2026-0349 | X | 1 | 4.9 | 4.9 | 4.9 | 3 Jun 2025 | 3 Jun 2025 |
| Astro PeptidesCASE #VI-2026-0424 | X | 1 | 4.6 | 4.6 | 4.6 | 13 Feb 2025 | 13 Feb 2025 |
| Shenzhen Jiechuang TradingCASE #VI-2026-0292 | X | 1 | 4.3 | 4.3 | 4.3 | 25 Apr 2025 | 25 Apr 2025 |
| Limitless Life NootropicsCASE #VI-2026-0980 | X | 1 | 3.5 | 3.5 | 3.5 | 6 May 2025 | 6 May 2025 |
| Modern AminosCASE #VI-2026-0635 | X | 1 | 3.2 | 3.2 | 3.2 | 28 Mar 2025 | 28 Mar 2025 |
| Guangzhou Yuao TradingCASE #VI-2026-0787 | X | 1 | 1.9 | 1.9 | 1.9 | 8 Jul 2025 | 8 Jul 2025 |
| HK Fat CatCASE #VI-2026-0376 | X | 1 | 1.4 | 1.4 | 1.4 | 13 Jun 2025 | 13 Jun 2025 |
| Lejian Biotech PeptideCASE #VI-2026-0746 | X | 1 | 0.0 | 0.0 | 0.0 | 16 Mar 2025 | 16 Mar 2025 |
| Peptide ArkCASE #VI-2026-0350 | X | 1 | 0.0 | 0.0 | 0.0 | 2 Apr 2025 | 2 Apr 2025 |
Open any subject to view the batch-level evidence for PEG MGF alone.